152 related articles for article (PubMed ID: 14520432)
21. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
22. Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia.
Daly AS; Kamel-Reid S; Lipton JH; Messner HA; Kiss TL; Chun K; Busque L; Chang H
Leuk Res; 2004 Oct; 28(10):1107-11. PubMed ID: 15289025
[TBL] [Abstract][Full Text] [Related]
23. Blood and marrow transplantation in the People's Republic of China.
Wu T; Lu DP
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S73-S75. PubMed ID: 18724310
[TBL] [Abstract][Full Text] [Related]
24. Chronic myelogenous leukemia and acute promyelocytic leukemia: new bone marrow transplantation options.
Viele CS
Oncol Nurs Forum; 1996 Apr; 23(3):488-93. PubMed ID: 8801509
[TBL] [Abstract][Full Text] [Related]
25. Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation.
Au WY; Lie AK; Lee CK; Liang R; Kwong YL
Bone Marrow Transplant; 1999 Jun; 23(11):1201-3. PubMed ID: 10382962
[TBL] [Abstract][Full Text] [Related]
26. Long-time survival after unrelated bone marrow transplantation in children and adolescents and targeted therapy with CD25 blockade to prevent GVHD.
Wawer A; Laws HJ; Dilloo D; Göbel U; Burdach S
Klin Padiatr; 2004; 216(3):169-75. PubMed ID: 15175962
[TBL] [Abstract][Full Text] [Related]
27. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
[TBL] [Abstract][Full Text] [Related]
28. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
29. Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation.
Sato M; Matsushima T; Takada S; Hatsumi N; Kim K; Sakuraya M; Saito T; Tamura J; Karasawa M; Murakami H; Naruse T
Bone Marrow Transplant; 1998 Dec; 22(12):1219-22. PubMed ID: 9894728
[TBL] [Abstract][Full Text] [Related]
30. Isolated testicular relapse in an adolescent 5 years following allogeneic bone marrow transplantation for acute myelogenous leukemia.
Lehmann LE; Guinan EC; Halpern SL; Donovan MJ; Bierer BE; Parsons SK
Bone Marrow Transplant; 1997 Apr; 19(8):849-51. PubMed ID: 9134181
[TBL] [Abstract][Full Text] [Related]
31. Isolated extramedullary relapse presenting as autologous lymphocyte response.
Imataki O; Ohnishi H; Kitanaka A; Kubota Y; Tanaka T; Ishida T
Am J Hematol; 2008 Jun; 83(6):512-4. PubMed ID: 18306363
[TBL] [Abstract][Full Text] [Related]
32. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
[TBL] [Abstract][Full Text] [Related]
34. Reciprocal bone marrow transplantation between brother and sister.
Rana I; Pinto RM; Caniglia M; Lombardi A; De Rossi G
Bone Marrow Transplant; 2002 Apr; 29(8):705-7. PubMed ID: 12180117
[TBL] [Abstract][Full Text] [Related]
35. [A successful allogeneic bone marrow transplantation for acute promyelocytic leukemia with anthracycline-induced cardiomyopathy at relapse].
Azuno Y; Hiroshige Y; Tanaka M; Nishimura Y; Tanaka H; Ueda K; Nishimura M; Okafuji K; Seguchi M; Yoshida T
Rinsho Ketsueki; 1992 Apr; 33(4):445-50. PubMed ID: 1602607
[TBL] [Abstract][Full Text] [Related]
36. Isolated extramedullary relapse in the pleural fluid of a patient with acute myeloid leukemia following allogeneic BMT.
Park J; Park SY; Cho HI; Lee D
Bone Marrow Transplant; 2002 Jul; 30(1):57-9. PubMed ID: 12105780
[TBL] [Abstract][Full Text] [Related]
37. HLA-identical haematopoietic stem cell transplantation for acute leukaemia in children: less relapse with higher biologically effective dose of TBI.
Willemze AJ; Geskus RB; Noordijk EM; Kal HB; Egeler RM; Vossen JM
Bone Marrow Transplant; 2007 Aug; 40(4):319-27. PubMed ID: 17572715
[TBL] [Abstract][Full Text] [Related]
38. [Cyclosporine-induced graft-versus-host disease in a syngeneic bone marrow transplantation].
Hashimoto S; Kawano E; Hirasawa A; Morio S; Aotuka N; Nakamura H; Oh H; Asai T; Yoshida S; Ishii G
Rinsho Ketsueki; 1993 Jan; 34(1):34-8. PubMed ID: 8450605
[TBL] [Abstract][Full Text] [Related]
39. Same sibling marrow following cord allogeneic transplantation as therapy for second relapse acute promyelocytic leukemia in a pediatric patient.
De Oliveira SN; Kao RL; Pham A; Smith LT; Kempert P; Moore TB
Pediatr Transplant; 2016 Mar; 20(2):337-41. PubMed ID: 26849401
[TBL] [Abstract][Full Text] [Related]
40. [Relapsed acute myeloid leukemia with Down syndrome showing long disease-free survival after bone marrow transplantation].
Daifu T; Kato I; Matubara H; Abe D; Uryu K; Tokumasu M; Umeda K; Watanabe K; Izawa K; Asai K; Nakahata T; Adachi S
Rinsho Ketsueki; 2009 Feb; 50(2):73-7. PubMed ID: 19265297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
